Search Results - "Lightstone, L"

Refine Results
  1. 1

    Minimising steroids in lupus nephritis – will B cell depletion pave the way? by Lightstone, L

    Published in Lupus (01-04-2013)
    “…The aim of this review is to briefly explore how steroids came to be a presumed adjunct to all treatment regimens for lupus nephritis, despite being the main…”
    Get full text
    Journal Article
  2. 2

    Severe pre-eclampsia and hypertensive crises by Arulkumaran, N., MRCP, Lightstone, L., PhD

    “…Hypertensive disorders of pregnancy are one of the leading causes of peripartum morbidity and mortality globally. Hypertensive disease in pregnancy is…”
    Get full text
    Journal Article
  3. 3

    Tacrolimus is an effective treatment for lupus nephritis in pregnancy by Webster, P, Wardle, A, Bramham, K, Webster, L, Nelson-Piercy, C, Lightstone, L

    Published in Lupus (01-10-2014)
    “…Lupus nephritis during pregnancy increases morbidity and mortality for mother and baby. Flares are difficult to treat as many therapeutic options are…”
    Get full text
    Journal Article
  4. 4

    Renoprotective strategies in lupus nephritis: beyond immunosuppression by Griffin, B, Lightstone, L

    Published in Lupus (01-10-2013)
    “…Lupus nephritis needs to be diagnosed promptly and treated specifically with appropriate immunosuppression. However, all patients with lupus nephritis have by…”
    Get full text
    Journal Article
  5. 5

    PO.5.114 Online education significantly improved rheumatologists’ knowledge of the burden of lupus nephritis and appropriate treatment strategies for patients by Bell, E, Calle, M, Lightstone, L

    Published in Lupus science & medicine (01-10-2022)
    “…Background/purposeLupus nephritis (LN) is the most common severe manifestation of SLE and can progress to end stage kidney disease within 15 years of diagnosis…”
    Get full text
    Journal Article
  6. 6

    European consensus statement on the terminology used in the management of lupus glomerulonephritis by Gordon, C, Jayne, D, Pusey, C, Adu, D, Amoura, Z, Aringer, M, Ballerin, J, Cervera, R, Calvo-Alén, J, Chizzolini, C, Dayer, JM, Doria, A, Ferrario, F, Floege, J, Guillevin, L, Haubitz, M, Hiepe, F, Houssiau, F, Lesavre, P, Lightstone, L, Meroni, PL, Meyer, O, Moulin, B, O’Reilly, K, Praga, M, Schulze-Koops, H, Sinico, RA, Smith, KGC, Tincani, A, Vasconcelos, C, Hughes, G

    Published in Lupus (01-03-2009)
    “…Systemic lupus erythematosus (SLE) is a complex, multisystem autoimmune disorder, which often involves referral to multiple medical specialists. Lupus…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post‐transcriptional regulation of the IFN‐γ/CXCL10 IP‐10 pathway by Ambrose, N., Khan, E., Ravindran, R., Lightstone, L., Abraham, S., Botto, M., Johns, M., Haskard, D. O.

    Published in Clinical and experimental immunology (01-09-2015)
    “…Summary The mechanisms underlying the exaggerated inflammatory response in Behçet's syndrome (BS) remain poorly understood. We investigated the response of…”
    Get full text
    Journal Article
  8. 8

    Urinary proteomic profiles distinguish between active and inactive lupus nephritis by MOSLEY, K, TAM, F. W. K, EDWARDS, R. J, CROZIER, J, PUSEY, C. D, LIGHTSTONE, L

    Published in Rheumatology (Oxford, England) (01-12-2006)
    “…Key aims of the treatment of lupus nephritis (LN) are to induce and maintain remission with minimal side effects. However, assessing ongoing renal inflammatory…”
    Get full text
    Journal Article
  9. 9

    Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study by Foschi, V, Bortolotti, D, Doyle, A F, Stratigou, V, Stephens, L, Trivedi, P, Rinaldi, R, Padovan, M, Bortoluzzi, A, Lightstone, L, Cairns, T D, Botto, M, Cook, T H, Rizzo, R, Govoni, M, Pickering, M C

    Published in Lupus (01-08-2019)
    “…Background The study aimed to investigate whether HLA-G antigen is expressed in the kidneys of patients affected by lupus nephritis (LN) and whether its…”
    Get full text
    Journal Article
  10. 10

    Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis by Yates, J, Whittington, A, Mitchell, P, Lechler, R.I, Lightstone, L, Lombardi, G

    Published in Clinical and experimental immunology (01-07-2008)
    “…CD4⁺ CD25⁺ regulatory T cells have been shown to be a vital component of the mechanisms that prevent autoreactivity in mice and also in humans. Previous…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Prevalence of chronic kidney disease in South Asian and Black minorities: findings from a population based screening study in London, UK by Roderick, P., Lightstone, L., Harris, S., Lapsley, M., Dockrell, M., Lim, E., Chambers, J., Kooner, J. S.

    “…Baseline assessment included renal function (serum creatinine converted to estimated glomerular filtration rate using 4 variable MDRD equations) and single…”
    Get full text
    Journal Article
  14. 14

    Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome by Glynne, Paul, Salama, Alan, Chaudhry, Afzal, Swirsky, David, Lightstone, Liz

    Published in American journal of kidney diseases (01-01-1999)
    “…Immune thrombocytopenic purpura (ITP) mediated by quinine-dependent platelet reactive antibodies is well recognized. More recently there have been a number of…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study by Howard, Luke, Abel, K, Altmann, D, Angyal, A, Ashworth, M, Assefa-Kebede, H, Baldry, E, Baldwin, D, Barratt, S, Bishop, L, Broome, M, Brown, M, Burns, G, Chetham, L, Choudhury, G, Coburn, Z, Cole, J, Connor, L, Coupland, C, Cross, A, Dalton, M, Davies, G A, Deakin, B, Defres, S, Diver, S, Dobson, S L, Drain, S, Fairbairn, S, Glossop, J, Greenhalgh, A, Gupta, A, Haggar, A, Harris, V, Harrison, E M, Hart, N, Heller, S, Hosseini, A, Hufton, E, Hussell, T, Ient, A, Ingram, L, Jacob, J, Johnston, D, Kausar, Z, Kelly, S, Khan, F, Korszun, A, Kwan, J, Laing, C, Lamlum, H, Lawrie, A, Lim, L, Lipman, M, Mackay, C, Man, W, Mayet, J, McAuley, H J C, McCann, G P, Mcgarvey, L, McGinness, J, McGuinness, H, McIvor, E, McNarry, M, Mitchell, J, Mohamed, A, Molyneaux, P L, Newell, H, Nicoll, D, Openshaw, P J M, Paradowski, K, Pariante, C, Pendlebury, J, Plekhanova, T, Quint, J, Qureshi, H, Rahman, N, Richardson, M, Rowland, M J, Russell, E, Sage, E K, Shaw, V, Southern, D, Spencer, L G, Stadon, L, Stockley, J, Storrie, A, Summers, C, Taylor, C, Turtle, L, Ugwuoke, R, Wall, E, Watson, J, Welch, C, Wilkinson, D, Williams-Howard, S A, Willis, G, Witham, M, Woods, J, Yasmin, S, Yousuf, A J

    Published in The lancet respiratory medicine (01-11-2021)
    “…The impact of COVID-19 on physical and mental health and employment after hospitalisation with acute disease is not well understood. The aim of this study was…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study by Fuld, J, Jenkins, R G, Man, W D-C, Openshaw, P J M, Scott, J T, Quint, J, Thorpe, M, Poinasamy, K, Harrison, E M, Ainsworth, M, Amoils, S, Armstrong, L, Atkin, C, Bain, S, Bates, A, Beckett, P, Bennett, K, Betts, S, Bhui, K, Brown, V, Buckley, P, Carr, C, Childs, C, Choudhury, N, Clohisey, S, Coakley, G, Cosier, T, Cuthbertson, D, Daly, P, Davies, G A, Davies, K, Dowling, R, Drury, K, Dunleavy, A, Evans, H, Evans, R, Finch, J, Fletcher, S, Francis, S, Frankel, A, Fu, X, Gooptu, B, Gregory, R, Hadley, K, Hall, L, Hanley, N A, Hazeldine, J, Heeley, C, Hiwot, T, Ismail, K, James, W Y, Jones, G, Kanellakis, N, Kelly, S, Kemp, G, Knight, S, Laing, C, Lea, A, Lingford-Hughes, A, Lota, H, Lye, A, Majeed, N, Mariveles, M, McArdle, A, McGarvey, L, McGinness, J, McGuinness, H, Monteiro, W, Needham, R, Neill, P, Newton-Cox, A, Noonan, M J, Norman, C, Nyaboko, J, O'Brien, L, Ostermann, M, Papineni, P, Patel, M, Powell, N, Price, L, Propescu, J, Rangeley, J, Redwood, D, Ross, A, Rossdale, J, Rowland, J, Sharma, M, Shaw, A, Shaw, K, Singh, S, Smith, D, Sykes, R, Thompson, A A R, Tomlinson, J, Tripp, K A, Ventura, M, Wight, A, Wilkinson, D, Willicombe, M, Young, S

    Published in The lancet respiratory medicine (01-08-2022)
    “…No effective pharmacological or non-pharmacological interventions exist for patients with long COVID. We aimed to describe recovery 1 year after hospital…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20